Artivion | CRY - 销售和管理费用

金融业

USD

USD 883.16M

现金及等价物

USD 55.76M

USD 42.85M

USD 357.52M

USD 92.7M

USD 317.78M

USD 4.79M

USD 22.72M

1.5K

EPS每股收益

USD -0.02

股本和储备

USD 450.47M

USD 73.14M

债务利息支出

USD 5.53M

USD -0.05

USD 215.35M

USD 1.03B

USD 2.42M

USD 111.2M

USD 4.79M

普通股股本

USD 47.84M

212.38

USD 11.4M

USD 115.99M

销售和管理费用

USD 55.75M

USD 98M

贸易债权人

USD 18.34M

应收帐款人

USD 103.68M

	销售和管理费用	更改		日
Abbott	USD 3.27B		138M	2026-03
Accuray	USD 124.78M		2.54M	2025-12
AngioDynamics	USD 36.57M		3.79M	2025-09
Artivion	USD 55.75M		4.54M	2025-12
AtriCure	USD 84.55M		6.21M	2026-03
Baxter International	USD 728M		33M	2026-03
Becton, Dickinson and Co.	USD 1.21B		180M	2026-03
Boston Scientific	USD 1.78B		53M	2026-03
Edwards Lifesciences	USD 522.2M		80.7M	2026-03
Inogen	USD 43.77M		510K	2024-06
Integra LifeSciences	USD 178.24M		21.79M	2026-03
J&J	USD 6.03B		719M	2026-03
Mesa Laboratories	USD 27.31M		380K	2024-09
Orthofix International	USD 130.35M		11.31M	2025-12
Pfizer	USD 2.92B		1.16B	2026-03
ResMed	USD 279.8M		1.4M	2026-03
Stryker	USD 2.15B		17M	2026-03
Tandem Diabetes Care	USD 99.86M		5.34M	2025-12
Teleflex	USD 226.01M		3.64M	2026-03
Terumo	JPY 114.81B		9.55B	2026-03
Trinity Biotech	USD 5.78M		405K	2025-12